EE05234B1 - 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks - Google Patents

6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks

Info

Publication number
EE05234B1
EE05234B1 EEP200300434A EEP200300434A EE05234B1 EE 05234 B1 EE05234 B1 EE 05234B1 EE P200300434 A EEP200300434 A EE P200300434A EE P200300434 A EEP200300434 A EE P200300434A EE 05234 B1 EE05234 B1 EE 05234B1
Authority
EE
Estonia
Prior art keywords
carboxamidoimidazo
gastric ulcer
pyridine compounds
induced gastric
prevent drug
Prior art date
Application number
EEP200300434A
Other languages
English (en)
Estonian (et)
Inventor
Eek Arne
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0100798A external-priority patent/SE0100798D0/xx
Priority claimed from SE0103291A external-priority patent/SE0103291D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200300434A publication Critical patent/EE200300434A/xx
Publication of EE05234B1 publication Critical patent/EE05234B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200300434A 2001-03-08 2002-03-05 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks EE05234B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100798A SE0100798D0 (sv) 2001-03-08 2001-03-08 New use
SE0103291A SE0103291D0 (sv) 2001-10-03 2001-10-03 New use
PCT/SE2002/000375 WO2002069968A1 (en) 2001-03-08 2002-03-05 New use

Publications (2)

Publication Number Publication Date
EE200300434A EE200300434A (et) 2003-12-15
EE05234B1 true EE05234B1 (et) 2009-12-15

Family

ID=26655407

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300434A EE05234B1 (et) 2001-03-08 2002-03-05 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks

Country Status (15)

Country Link
US (2) US20040082605A1 (cs)
EP (1) EP1370261A2 (cs)
JP (1) JP2004520422A (cs)
KR (1) KR100904599B1 (cs)
CN (1) CN1496259A (cs)
BG (1) BG108144A (cs)
BR (1) BR0207762A (cs)
CA (1) CA2440100A1 (cs)
CZ (1) CZ20032398A3 (cs)
EE (1) EE05234B1 (cs)
IL (1) IL157461A0 (cs)
MX (1) MXPA03007888A (cs)
NO (1) NO20033919L (cs)
SK (1) SK10982003A3 (cs)
WO (1) WO2002069968A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
ES2293068T3 (es) * 2002-09-19 2008-03-16 Schering Corporation Imidazopiridinas como inhibidores de quinasas dependientes de ciclina.
KR20050072090A (ko) * 2002-09-19 2005-07-08 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 피라졸로피리딘
US20060154954A1 (en) * 2003-02-17 2006-07-13 Altana Pharma Ag Combinations and use of selected pharmaceutically active compounds
WO2011102460A1 (ja) * 2010-02-19 2011-08-25 学校法人関西医科大学 胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3922387A1 (de) * 1989-07-07 1991-01-17 Kali Chemie Pharma Gmbh N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
KR920002148A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
EP0550083B1 (en) * 1991-12-06 1999-03-24 Glaxo Group Limited Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
HUP0102990A3 (en) * 1998-09-23 2002-09-30 Altana Pharma Ag Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
ATE240956T1 (de) * 1999-04-17 2003-06-15 Altana Pharma Ag Haloalkoxy-imidazonaphthyridine

Also Published As

Publication number Publication date
JP2004520422A (ja) 2004-07-08
BG108144A (en) 2004-09-30
CZ20032398A3 (cs) 2004-02-18
US20090170854A1 (en) 2009-07-02
US20040082605A1 (en) 2004-04-29
NO20033919D0 (no) 2003-09-04
CN1496259A (zh) 2004-05-12
IL157461A0 (en) 2004-03-28
WO2002069968A8 (en) 2003-04-17
NO20033919L (no) 2003-09-04
KR20040007461A (ko) 2004-01-24
KR100904599B1 (ko) 2009-06-25
BR0207762A (pt) 2004-06-01
SK10982003A3 (sk) 2004-02-03
EP1370261A2 (en) 2003-12-17
CA2440100A1 (en) 2002-09-12
WO2002069968A1 (en) 2002-09-12
EE200300434A (et) 2003-12-15
MXPA03007888A (es) 2003-12-04

Similar Documents

Publication Publication Date Title
IL154310A0 (en) Heterocyclic compounds as ligands of the gabaa receptor
IS8009A (is) 5,7-díamínópýrasóló [4,3-d] pýridín nytsamleg viðmeðferð á háþrýstingi
DK1381363T3 (da) Imidazo[1,2-a]pyridinderivater som mGluR5-antagonister
NO20032453L (no) Substituerte imidazopyridiner
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DE60216115D1 (de) BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
AU2001255277A1 (en) Use of moving element to produce heat
ID26626A (id) Derivat-derivat 2-piridilmetilamin yang berguna sebagai fungisida-fungisida
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
DE60205921D1 (de) SUBSTITUIERTE 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDOç1,2-A!PYRIMIDIN-4-ON- UND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO-ç1,2-A!PYRIMIDIN-5(1H)ONDERIVATE
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
JP2004510774A5 (cs)
NO20022554D0 (no) Additivformulering for oljeproduksjon
EE05234B1 (et) 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
NO20031314L (no) Bicykliske heteroaromatiske forbindelser
NO20026155D0 (no) Fremgangsmåte for fremstilling av lavere olefiner
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
DE60039998D1 (de) Pentacyclische taxan-verbindungen
ATE269383T1 (de) Benzin-sauerstoffverbindungen-gemisch
ID24327A (id) Produksi senyawa-senyawa avermektin
NO20025465L (no) Fremgangsmåte for fremstilling av bifenylforbindelser
FI20010835A0 (fi) Jäähileen tuotantolaitteisto
FR2807033B1 (fr) Compositions de mono- et poly- benzyl-1,2,3,4- tetrahydronaphtalenes
SE0000620D0 (sv) Novel compounds

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110305